scispace - formally typeset
L

Laurie H. Glimcher

Researcher at Harvard University

Publications -  469
Citations -  73810

Laurie H. Glimcher is an academic researcher from Harvard University. The author has contributed to research in topics: T cell & Major histocompatibility complex. The author has an hindex of 135, co-authored 466 publications receiving 68983 citations. Previous affiliations of Laurie H. Glimcher include University Health Network & Cornell University.

Papers
More filters
Journal ArticleDOI

Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes

TL;DR: It is shown that obesity causes endoplasmic reticulum (ER) stress, which leads to suppression of insulin receptor signaling through hyperactivation of c-Jun N-terminal kinase (JNK) and subsequent serine phosphorylation of insulin receptors substrate–1 (IRS-1).
Journal ArticleDOI

A novel transcription factor, T-bet, directs Th1 lineage commitment.

TL;DR: T-bet initiates Th1 lineage development from naive Thp cells both by activating Th1 genetic programs and by repressing the opposing Th2 programs, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.
Journal ArticleDOI

XBP-1 Regulates a Subset of Endoplasmic Reticulum Resident Chaperone Genes in the Unfolded Protein Response

TL;DR: It is suggested that the IRE1/XBP-1 pathway is required for efficient protein folding, maturation, and degradation in the ER and imply the existence of subsets of UPR target genes as defined by their dependence on XBP- 1.
Journal ArticleDOI

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy

TL;DR: Interaction of B 7-1 and B7-2 with shared counterreceptors CD28 and CTLA-4 results in very different outcomes in clinical disease by influencing commitment of precursors to a Th1 or Th2 lineage.
Journal ArticleDOI

XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease

TL;DR: It is reported that XBP1 deletion in intestinal epithelial cells (IECs) results in spontaneous enteritis and increased susceptibility to induced colitis secondary to both Paneth cell dysfunction and an epithelium that is overly reactive to inducers of IBD such as bacterial products (flagellin) and TNFalpha.